Cargando…
Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome
OBJECTIVES: The purpose of the present study was to investigate the safety and tolerability of the monoaminergic stabilizer (‐)‐OSU6162 in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In addition, a potential therapeutic effect of (‐)‐OSU6162 in ME/CFS was evaluated by...
Autores principales: | Haghighi, Sara, Forsmark, Sara, Zachrisson, Olof, Carlsson, Arvid, Nilsson, Marie K. L., Carlsson, Maria L., Schuit, Robert C., Gottfries, Carl‐Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035472/ https://www.ncbi.nlm.nih.gov/pubmed/33528911 http://dx.doi.org/10.1002/brb3.2040 |
Ejemplares similares
-
Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia
por: Regland, Björn, et al.
Publicado: (2015) -
Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence
por: Khemiri, Lotfi, et al.
Publicado: (2019) -
The effects of the dopamine stabilizer (−)-OSU6162 on aggressive and sexual behavior in rodents
por: Studer, E, et al.
Publicado: (2016) -
Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Blomberg, Jonas, et al.
Publicado: (2019) -
The monoamine stabilizer (−)‐OSU6162 prevents the alcohol deprivation effect and improves motor impulsive behavior in rats
por: Fredriksson, Ida, et al.
Publicado: (2018)